title: Connective tissue growth factor (CTGF/CCN2) is negatively regulated during neuron-glioblastoma interaction.
abstract: Connective-tissue growth factor (CTGF/CCN2) is a matricellular-secreted protein involved in complex processes such as wound healing, angiogenesis, fibrosis and metastasis, in the regulation of cell proliferation, migration and extracellular matrix remodeling. Glioblastoma (GBM) is the major malignant primary brain tumor and its adaptation to the central nervous system microenvironment requires the production and remodeling of the extracellular matrix. Previously, we published an in vitro approach to test if neurons can influence the expression of the GBM extracellular matrix. We demonstrated that neurons remodeled glioma cell laminin. The present study shows that neurons are also able to modulate CTGF expression in GBM. CTGF immnoreactivity and mRNA levels in GBM cells are dramatically decreased when these cells are co-cultured with neonatal neurons. As proof of particular neuron effects, neonatal neurons co-cultured onto GBM cells also inhibit the reporter luciferase activity under control of the CTGF promoter, suggesting inhibition at the transcription level. This inhibition seems to be contact-mediated, since conditioned media from embryonic or neonatal neurons do not affect CTGF expression in GBM cells. Furthermore, the inhibition of CTGF expression in GBM/neuronal co-cultures seems to affect the two main signaling pathways related to CTGF. We observed inhibition of TGFβ luciferase reporter assay; however phopho-SMAD2 levels did not change in these co-cultures. In addition levels of phospho-p44/42 MAPK were decreased in co-cultured GBM cells. Finally, in transwell migration assay, CTGF siRNA transfected GBM cells or GBM cells co-cultured with neurons showed a decrease in the migration rate compared to controls. Previous data regarding laminin and these results demonstrating that CTGF is down-regulated in GBM cells co-cultured with neonatal neurons points out an interesting view in the understanding of the tumor and cerebral microenvironment interactions and could open up new strategies as well as suggest a new target in GBM control.
authors: Universidade Federal do Rio de Janeiro, Campus Macaé, Rio de Janeiro, Brazil.
authors: Luciana F
authors: LF
authors: Romão
authors: Fabio A
authors: FA
authors: Mendes
authors: Natalia M
authors: NM
authors: Feitosa
authors: Jane Cristina O
authors: JC
authors: Faria
authors: Juliana M
authors: JM
authors: Coelho-Aguiar
authors: Jorge Marcondes
authors: JM
authors: de Souza
authors: Vivaldo
authors: V
authors: Moura Neto
authors: José Garcia
authors: JG
authors: Abreu
mesh_terms: D000818:Animals; D002450:Cell Communication; D045744:Cell Line, Tumor; D002465:Cell Movement; D018920:Coculture Techniques; D055513:Connective Tissue Growth Factor / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D005909:Glioblastoma / Q000235:genetics / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D010766:Phosphorylation; D061251:Primary Cell Culture; D011401:Promoter Regions, Genetic; D051381:Rats; D015398:Signal Transduction; D051899:Smad2 Protein / Q000378:metabolism; D051900:Smad3 Protein / Q000378:metabolism; D015533:Transcriptional Activation; D016212:Transforming Growth Factor beta / Q000378:metabolism
chemical_list: D051899:Smad2 Protein; D051900:Smad3 Protein; D016212:Transforming Growth Factor beta; D055513:Connective Tissue Growth Factor; D048052:Mitogen-Activated Protein Kinase 3
references: FASEB J. 2006 Aug;20(10):1712-4
references: 16790529
references: Anticancer Drugs. 2009 Aug;20(7):543-52
references: 19491660
references: J Neurooncol. 2006 Sep;79(2):125-33
references: 16598423
references: Expert Opin Emerg Drugs. 2008 Mar;13(1):81-94
references: 18321150
references: Exp Cell Res. 2007 Mar 10;313(5):952-64
references: 17239853
references: Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7526-31
references: 10377448
references: J Biol Chem. 2001 Apr 6;276(14):10594-601
references: 11152469
references: Glia. 2007 Aug 1;55(10):1023-33
references: 17549683
references: Exp Oncol. 2010 Mar;32(1):2-9
references: 20332765
references: Biochem Biophys Res Commun. 2002 Jul 26;295(4):1014-9
references: 12127997
references: Nat Rev Neurosci. 2002 Jun;3(6):423-32
references: 12042877
references: Exp Cell Res. 1997 May 25;233(1):63-77
references: 9184077
references: J Endocrinol. 1997 Jul;154(1):167-75
references: 9246951
references: Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1903-10
references: 19011018
references: J Neurosci Res. 1995 Jun 15;41(3):409-17
references: 7563234
references: Science. 2002 Sep 6;297(5587):1660-3
references: 12215636
references: J Cell Biol. 1985 Feb;100(2):384-96
references: 3881455
references: J Physiol. 2001 Jun 15;533(Pt 3):665-79
references: 11410625
references: Brain Res Dev Brain Res. 2003 May 14;142(2):111-9
references: 12711362
references: Eur J Neurosci. 2000 Jan;12(1):376-80
references: 10651893
references: Growth Factors. 1999;17(2):115-24
references: 10595311
references: Cell Growth Differ. 1997 Jan;8(1):61-8
references: 8993835
references: FASEB J. 2004 Dec;18(15):1920-1
references: 15469966
references: Neuron. 2000 Aug;27(2):197-200
references: 10985340
references: Life Sci. 2011 Oct 10;89(15-16):532-9
references: 21641917
references: Arch Oral Biol. 2003 Feb;48(2):111-6
references: 12642229
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: Glia. 2000 Feb 1;29(3):260-72
references: 10642752
references: Science. 2001 Jan 26;291(5504):657-61
references: 11158678
references: J Neurochem. 2011 Oct;119(1):113-23
references: 21834854
references: Anticancer Res. 2010 Feb;30(2):391-7
references: 20332444
references: Eur J Neurosci. 2004 Apr;19(7):1721-30
references: 15078546
references: J Neurosci. 2001 Apr 15;21(8):2749-58
references: 11306627
references: Mol Pathol. 1997 Dec;50(6):310-6
references: 9536281
references: Nat Cell Biol. 2002 Aug;4(8):599-604
references: 12134160
references: Brain Res. 1999 Jul 10;834(1-2):146-51
references: 10407104
references: Cell Growth Differ. 1996 Apr;7(4):469-80
references: 9052988
references: Life Sci. 2011 Oct 10;89(15-16):524-31
references: 21569780
references: BMC Genomics. 2008 Jan 29;9:54
references: 18230158
references: Nature. 2002 May 2;417(6884):39-44
references: 11986659
references: Dev Biol. 1993 Mar;156(1):34-48
references: 7680631
references: Differentiation. 2006 Dec;74(9-10):562-72
references: 17177853
references: Oncogene. 2007 May 14;26(22):3291-310
references: 17496923
references: Cancer Res. 2008 Sep 1;68(17):6978-86
references: 18757412
references: J Neurochem. 2008 Apr;105(2):287-95
references: 18284616
references: Oncogene. 1999 Mar 18;18(11):2033-7
references: 10208426
references: FEBS Lett. 1993 Jul 26;327(2):125-30
references: 7687569
references: Cytokine Growth Factor Rev. 1997 Sep;8(3):171-9
references: 9462483
references: J Natl Cancer Inst. 2011 Aug 3;103(15):1162-78
references: 21771732
references: Oncogene. 2010 Jun 10;29(23):3411-22
references: 20305691
references: Neurol Res. 2002 Oct;24(7):677-83
references: 12392205
references: Clin Cancer Res. 2004 Mar 15;10(6):2072-81
references: 15041728
references: J Bone Miner Res. 2005 May;20(5):867-77
references: 15824860
references: Endocr Rev. 1999 Apr;20(2):189-206
references: 10204117
references: Gene. 2002 Apr 3;287(1-2):39-47
references: 11992721
references: Int J Biochem Cell Biol. 1997 Mar;29(3):401-14
references: 9202420
references: J Cell Biol. 1987 May;104(5):1353-60
references: 3571332
references: Science. 1996 Nov 15;274(5290):1123-33
references: 8895455
references: Science. 1997 Sep 12;277(5332):1684-7
references: 9287225
references: J Neurosci Res. 1995 Mar 1;40(4):471-7
references: 7616607
references: Glia. 1999 Apr;26(2):97-108
references: 10384875
references: Cancer Cell. 2003 Jun;3(6):537-49
references: 12842083
references: J Biol Chem. 2002 Nov 15;277(46):44187-94
references: 12218048
references: Glia. 2011 Aug;59(8):1181-9
references: 21192095
references: Life Sci. 2011 Oct 10;89(15-16):545-54
references: 21635906
references: Nature. 2010 Nov 11;468(7321):223-31
references: 21068831
references: Glia. 1999 Feb 1;25(3):247-55
references: 9932871
references: Anticancer Res. 2010 Apr;30(4):1209-15
references: 20530430
references: Eur J Biochem. 2001 Dec;268(23):6058-65
references: 11732999
references: Kidney Int. 2002 Oct;62(4):1149-59
references: 12234285
references: J Biochem. 2009 Feb;145(2):207-16
references: 19038999
references: J Biol Chem. 2003 Apr 11;278(15):13008-15
references: 12571253
references: Eur J Neurosci. 2002 Dec;16(11):2059-69
references: 12473073
references: J Biomed Sci. 2008 Nov;15(6):675-85
references: 18622762
references: Int J Cancer. 2010 Nov 15;127(10):2257-67
references: 20162579
references: Nat Med. 2001 Sep;7(9):1010-5
references: 11533703